Rosette-forming lymphocytes and measles vaccination. 1976

C Mandalenaki-Asfi, and P Liakopoulou, and M Apostolou, and T Thomaidis, and N Mastsaniotis

UI MeSH Term Description Entries
D007104 Immune Adherence Reaction A method for the detection of very small quantities of antibody in which the antigen-antibody-complement complex adheres to indicator cells, usually primate erythrocytes or nonprimate blood platelets. The reaction is dependent on the number of bound C3 molecules on the C3b receptor sites of the indicator cell. Adherence Reaction, Immune,Adherence Reactions, Immune,Immune Adherence Reactions,Reaction, Immune Adherence,Reactions, Immune Adherence
D007223 Infant A child between 1 and 23 months of age. Infants
D008458 Measles Vaccine A live attenuated virus vaccine of chick embryo origin, used for routine immunization of children and for immunization of adolescents and adults who have not had measles or been immunized with live measles vaccine and have no serum antibodies against measles. Children are usually immunized with measles-mumps-rubella combination vaccine. (From Dorland, 28th ed) Vaccine, Measles
D008459 Measles virus The type species of MORBILLIVIRUS and the cause of the highly infectious human disease MEASLES, which affects mostly children. Edmonston virus
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013601 T-Lymphocytes Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new T cells sensitized to that antigen. T Cell,T Lymphocyte,T-Cells,Thymus-Dependent Lymphocytes,Cell, T,Cells, T,Lymphocyte, T,Lymphocyte, Thymus-Dependent,Lymphocytes, T,Lymphocytes, Thymus-Dependent,T Cells,T Lymphocytes,T-Cell,T-Lymphocyte,Thymus Dependent Lymphocytes,Thymus-Dependent Lymphocyte
D014613 Vaccines, Attenuated Live vaccines prepared from microorganisms which have undergone physical adaptation (e.g., by radiation or temperature conditioning) or serial passage in laboratory animal hosts or infected tissue/cell cultures, in order to produce avirulent mutant strains capable of inducing protective immunity. Attenuated Vaccine,Vaccines, Live, Attenuated,Attenuated Vaccines,Vaccine, Attenuated

Related Publications

C Mandalenaki-Asfi, and P Liakopoulou, and M Apostolou, and T Thomaidis, and N Mastsaniotis
January 1977, Boletin medico del Hospital Infantil de Mexico,
C Mandalenaki-Asfi, and P Liakopoulou, and M Apostolou, and T Thomaidis, and N Mastsaniotis
January 1977, Voprosy onkologii,
C Mandalenaki-Asfi, and P Liakopoulou, and M Apostolou, and T Thomaidis, and N Mastsaniotis
October 1973, The New England journal of medicine,
C Mandalenaki-Asfi, and P Liakopoulou, and M Apostolou, and T Thomaidis, and N Mastsaniotis
January 1987, Laboratornoe delo,
C Mandalenaki-Asfi, and P Liakopoulou, and M Apostolou, and T Thomaidis, and N Mastsaniotis
October 1979, Journal of immunology (Baltimore, Md. : 1950),
C Mandalenaki-Asfi, and P Liakopoulou, and M Apostolou, and T Thomaidis, and N Mastsaniotis
January 1982, Medecine interne,
C Mandalenaki-Asfi, and P Liakopoulou, and M Apostolou, and T Thomaidis, and N Mastsaniotis
January 1975, British medical journal,
C Mandalenaki-Asfi, and P Liakopoulou, and M Apostolou, and T Thomaidis, and N Mastsaniotis
May 1978, Acta neurologica Scandinavica,
C Mandalenaki-Asfi, and P Liakopoulou, and M Apostolou, and T Thomaidis, and N Mastsaniotis
January 1976, Journal of immunological methods,
C Mandalenaki-Asfi, and P Liakopoulou, and M Apostolou, and T Thomaidis, and N Mastsaniotis
March 1976, Lancet (London, England),
Copied contents to your clipboard!